Biora Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
DEF 14A: Biora Therapeutics Seeks Stockholder Approval for Share Issuance and Incentive Plan Amendment
Biora Therapeutics is holding a special meeting to seek stockholder approval for issuing shares related to convertible notes and warrants, as well as to amend its equity incentive plan.
DEF 14A: Biora Therapeutics Seeks Stockholder Approval for Reverse Stock Split to Maintain Nasdaq Listing
Biora Therapeutics is asking stockholders to approve a reverse stock split and a reduction in authorized shares to regain compliance with Nasdaq listing requirements.
Biora Therapeutics is holding its annual stockholder meeting on June 5, 2024, seeking approval for director elections, auditor ratification, an increase in authorized shares, and authorization for the issuance of shares related to recent warrant agreements.
Biora Therapeutics is holding its 2024 Annual Meeting of Stockholders on June 5, 2024, to vote on key proposals including the election of directors, ratification of the independent auditor, increasing authorized shares, and authorizing the issuance of shares underlying certain warrants.